SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
SEC Accession No. 0001144204-09-008228
Filing Date
2009-02-13
Accepted
2009-02-13 17:13:51
Documents
4
Period of Report
2008-12-31
Filing Date Changed
2009-02-13

Document Format Files

Seq Description Document Type Size
1 v140066_10q.htm 10-Q 1571857
2 v140066_ex31-1.htm EX-31.1 9296
3 v140066_ex31-2.htm EX-31.2 9235
4 v140066_ex32-1.htm EX-32.1 6675
  Complete submission text file 0001144204-09-008228.txt   1598849
Mailing Address MIDDLE SECTION, LONGMAO STREET, AREA A LAIYANG WAIXIANGXING INDUSTRIAL PARK LAIYANG CITY, YANTAI F4 710075
Business Address MIDDLE SECTION, LONGMAO STREET, AREA A LAIYANG WAIXIANGXING INDUSTRIAL PARK LAIYANG CITY, YANTAI F4 710075 5619889880
Genesis Pharmaceuticals Enterprises, Inc. (Filer) CIK: 0001091164 (see all company filings)

IRS No.: 651130026 | State of Incorp.: FL | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-53037 | Film No.: 09605205
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1